Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 30 Jul 20 424B4 Prospectus supplement with pricing info
- 30 Jul 20 EFFECT Notice of effectiveness
-
23 Jul 20 S-1/A IPO registration (amended)
- 6 Jul 20 S-1 IPO registration
ALVR similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement No. 333-239698 on Form S-1 of our report dated June 3, 2020 (July 23, 2020 as to the effects of the reverse stock split described in Note 19) relating to the financial statements of AlloVir, Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
July 23, 2020